Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Marker, Biological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01827423
What this trial is testing

Squamous Cell Carcinoma Antigen Analysis at the University Hospital Ostrava

Who this might be right for
Nasal PolypsNasal DiseasesPapilloma
University Hospital Ostrava 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT07105384
What this trial is testing

Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy

Who this might be right for
Parkinson Disease
Fundacion Clinic per a la Recerca Biomédica 66
Post-approval studies (Phase 4)Study completedNCT00447148
What this trial is testing

Standard vs. 3-Dimensional Coronary Angiography: a Paired Comparison

Who this might be right for
Coronary Artery Disease
Antwerp Cardiovascular Institute Middelheim 36
Not applicableStudy completedNCT05569499
What this trial is testing

Hematocrit Evolution in Severe Burns

Who this might be right for
Severe Skin Burns
Centre Hospitalier Régional Metz-Thionville 230
Not applicableUnknownNCT03953404
What this trial is testing

POC SPLA2-IIA as a Biomarker for Sepsis and Septic Shock

Who this might be right for
Sepsis
St. Luke's Hospital, Pennsylvania 450
Not applicableLooking for participantsNCT07737509
What this trial is testing

Understanding the Genetic and Biological Factors That Influence Cancer Treatment Response and Resistance in Patients With Advanced Solid Tumours Through Sample Analysis

Who this might be right for
Advanced Solid Tumours
Institute of Cancer Research, United Kingdom 5,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05826964
What this trial is testing

Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer

Who this might be right for
Breast CancerER-positive Breast CancerHER2-negative Breast Cancer+1 more
University of Miami 24
Not applicableStudy completedNCT01367093
What this trial is testing

French and EuRopean Outcome Registry in Intensive Care Unit

Who this might be right for
Intensive Care Unit SyndromeTracheal Intubation Morbidity
Assistance Publique - Hôpitaux de Paris 2,137
Not applicableUnknownNCT04728139
What this trial is testing

Assessment of Glypican 3 as Apredictive Marker in Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
Assiut University 90
Not applicableLooking for participantsNCT07068529
What this trial is testing

Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：MetBio-CRC

Who this might be right for
Colorectal Cancer
Shanghai Minimally Invasive Surgery Center 250
Not applicableWithdrawnNCT01202539
What this trial is testing

Real-time Assessment of Frameless Intrafraction Motion

Who this might be right for
Brain Tumor
Oregon Health and Science University
Not applicableNot Yet RecruitingNCT07673783
What this trial is testing

Outlining Biological Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients.

Who this might be right for
Parkinson Disease (PD)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 90
Not applicableUnknownNCT02100202
What this trial is testing

Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia

Who this might be right for
Chronic SmokersHyperlipidemia
Olive Lifesciences Pvt Ltd 60
Not applicableStudy completedNCT02565602
What this trial is testing

Comparison of Calcium Metabolism in Caucasian and Asian Postmenopausal Women of Chinese Descent and the Use of Strontium as a Qualitative Marker of Calcium Metabolism

Who this might be right for
Calcium Metabolism
National University of Singapore 10
Not applicableUnknownNCT00400894
What this trial is testing

Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma

Who this might be right for
Prostate CancerBenign Prostatic HyperplasiaProstatic Intraepithelial Neoplasia
ProteoSys AG 750
Not applicableStudy completedNCT02194439
What this trial is testing

Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease

Who this might be right for
Graft-Versus-Host Disease
Indiana University 415
Not applicableStudy completedNCT02867670
What this trial is testing

TMS as a Biological Marker of Neuroplasticity

Who this might be right for
StrokeAphasia
University of Pennsylvania 41
Large-scale testing (Phase 3)Active Not RecruitingNCT04565054
What this trial is testing

Adjuvant Therapy With Abemaciclib + SOC ET vs. SOC ET in Clinical or Genomic High Risk, HR+/HER2- EBC

Who this might be right for
Breast Cancer Female
Women's Cancer Study Group GmbH 1,260
Not applicableStudy completedNCT01942005
What this trial is testing

EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed Patients

Who this might be right for
ImmunosuppressionNeoplasm
Andreas Arnold 144
Early research (Phase 1)Study completedNCT00970229
What this trial is testing

Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.

Who this might be right for
Parkinson DiseaseHuntington Disease
Institute for Neurodegenerative Disorders 19
Next Page